Copyright
©The Author(s) 2000.
World J Gastroenterol. Jun 15, 2000; 6(3): 315-323
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.315
Published online Jun 15, 2000. doi: 10.3748/wjg.v6.i3.315
Table 1 Principles of management of acute severe ulcerative colitis
| GENERAL MEASURES |
| Explanation, psychosocial support |
| - patient support groups |
| Specialist multidisciplinary care |
| - physicians, surgeons, nutrition team, nurses, stoma therapist, counsellor |
| ESTABLISHING THE DIAGNOSIS, EXTENT/SITE AND SEVERITY |
| - clinical evaluation |
| - FBC, ESR, C reactive protein, albumin, LFTs, amoebic serology |
| - stool microscopy, culture, C. difficile toxin |
| - limited sigmoidoscopy and biopsy |
| - plain abdominal X-ray |
| - consider radiolabelled leucocyte scan |
| MONITORING PROGRESS |
| - daily clinical assessment |
| - stool chart |
| - 4-hrly temperature, pulse |
| - daily FBC, ESR, C-reactive protein, urea and electrolytes, albumin |
| - daily plain abdominal X-ray |
| SUPPORTIVE TREATMENT |
| - i.v. fluids, electrolytes (Na, K), blood transfusion |
| - nutritional supplementation |
| - heparin s.c. |
| - haematinics (folate) |
| -avoid antidiarrhoeals (codeine, loperamide, diphenoxylate), opiates, NSAIDs |
| - rolling manoeuvre (if colon dilating) |
| SPECIFIC TREATMENT |
| Medical - corticosteroids i.v. (hydrocortisone or methylprednisolone) then p.o. (prednisolone) |
| -continue 5-ASA p.o. in patients already taking it; otherwise start when improvement begins |
| -antibiotics for very sick febrile patients, or when infection suspected |
| -consider cyclosporin i.v. then p.o.) for steroid non-responders at 4-7 d |
| Surgical (for non-responders at 5-7 d, toxic megacolon, perforation, massive haemorrhage) |
| - panproctocolectomy with ileoanal pouch or permanent ileostomy |
| - subtotal colectomy with ileorectal anastomosis (rarely) |
Table 2 Management of active ileocaecal Crohn's disease. General measures, monitoring progress and supportive treatment are essentially as for ulcerative colitis
| ESTABLISHING THE DIAGNOSIS, EXTENT/SITE AND SEVERITY |
| - clinical evaluation |
| - FBC, ESR, C-reactive protein, ferritin, folate, B12, albumin, LFTs, Ca, Mg, Zn |
| - stool microscopy, culture, C difficile toxin |
| - plain abdominal X-ray |
| - consider colonoscopy and biopsy, small bowel barium radiology, ultrasound, CT, MRI, leucocyte scan |
| SPECIFIC TREATMENT (separately or in combination) |
| Medical - corticosteroids i.v. (hydrocortisone or methyl prednisolone) then p.o. (prednisolone or budesonide CR) |
| - continue high dose mesalazine (Pentasa or Asacol) in patients already taking it; otherwise start when improvement begins |
| - consider metronidazole, ciprofloxacin; also broad spectrum antibiotics for very sick febrile patients, or when infection/collection suspected |
| - consider azathioprine/6-mercaptopurine (slow response) or anti TNF antibodies (infliximab) for steroid non-responders |
| Nutritional - liquid formula diet |
| Endoscopic - balloon dilatation |
| Surgical - resection or stricturoplasty |
- Citation: Rampton DS. Management of difficult inflammatory bowel disease: where are we now? World J Gastroenterol 2000; 6(3): 315-323
- URL: https://www.wjgnet.com/1007-9327/full/v6/i3/315.htm
- DOI: https://dx.doi.org/10.3748/wjg.v6.i3.315
